基于微信平台的简易自我管理项目对中年心血管病高危者血脂的影响

Effect of simple self-management project based on WeChat platform on blood lipids of middle-aged high-risk patients with cardiovascular disease

目的评价基于微信平台(公众号和微信群)的简易自我管理项目对中年心血管病高危者血脂水平的影响。方法随机抽取105例中年心血管病高危者,借助微信平台创建公众号和微信群,进行信息发布、医患互动、同伴支持、病情监测与反馈等自我管理教育与支持措施,评价1年2月该院个月后血脂的变化。结果干预前后患者TC、TG HDL-C及LDL-C变化比较,差异均有统计学意义(均P<0.001);经非参数检验显示,不同平均收缩压、BMI和心血管疾病史的研究对象干预前后TG变化比较,差异均有统计学意义(P<0.05);不同BMI和心血管疾病史的研究对象干预前后HDL-C变化比较,差异均有统计学意义(均P<0.05);不同年龄、平均收缩压和心血管疾病史的研究对象干预前后LDL-C变化比较,差异均有统计学意义(均P<0.05)。结论基于微信平台的自我管理项目是一种简单、有效的干预模式,能改善中年心血管病高危人群血脂水平,对收缩压、BMI增高及有心血管病史者的血脂改善效果更明显。

Objective To evaluate the effect of simple self-management project based on WeChat platform (public account and WeChat group) on blood lipid level in middle-aged high-risk patients with cardiovascular disease. Methods A total of 105 middle-aged cardiovascular high-risk patients were randomly selected, and public accounts and WeChat groups were created on WeChat platform to conduct self-management education and support measures, such as information release, doctor-patient interaction, peer support, condition monitoring and feedback, to evaluate the changes of blood lipids in the hospital after one year and two months. Results Changes in TC, TG HDL-C and LDL-C of patients before and after intervention were statistically significant (P<0.001). Non-parametric test showed that TG changes of subjects with different mean systolic blood pressure, BMI and cardiovascular disease history before and after intervention were statistically significant (P<0.05). Changes of HDL-C before and after intervention in subjects with different BMI and cardiovascular disease history were statistically significant (P<0.05). There were statistically significant differences in LDL-C before and after intervention among subjects of different ages, mean systolic blood pressure and cardiovascular disease history (P<0.05). Conclusion Self-management project based on WeChat platform is a simple and effective intervention mode, which can improve blood lipid level in middle-aged high-risk cardiovascular disease population, and have a more obvious effect on blood lipid improvement in patients with increased systolic blood pressure, BMI and cardiovascular history.